These data suggest that the enhanced asthma-related features in HDM-treated Tet1−/− mice are not due to increased dsDNA ligand binding to toll receptors triggering downstream IFN signaling, but rather due to the loss of transcriptional modulation of components of the IFN signaling pathway by Tet1. This evidence concerns the gene TET1 and asthma.